SCHEMBL16812

SCHEMBL16812

O=S(=O)(C1=CC=CCC1=S)N1CCNC(CC2CCOCC2)C1

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCKR Q14397 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17471 0.99
SCHEMBL17125 0.82
SCHEMBL16867 0.79 GCKR (0.33) GCKR
Hydrochloric Acid SCHEMBL23484 0.78 GCKR (0.33) GCKR
SCHEMBL12078539 0.78 CYP3A4 (0.40)
SCHEMBL16420 0.77 CA1 (0.41)
Hydrochloric Acid SCHEMBL16218 0.77 CYP3A4 (0.40)
SCHEMBL12077490 0.73 CTSL (0.34)
SCHEMBL16814 0.73
SCHEMBL22891 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed